Product NDC: | 10019-450 |
Proprietary Name: | Metoclopramide |
Non Proprietary Name: | Metoclopramide Hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; Metoclopramide Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-450 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017862 |
Marketing Category: | NDA |
Start Marketing Date: | 20101209 |
Package NDC: | 10019-450-02 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 CARTON (10019-450-02) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-450-39) |
NDC Code | 10019-450-02 |
Proprietary Name | Metoclopramide |
Package Description | 25 VIAL, SINGLE-DOSE in 1 CARTON (10019-450-02) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-450-39) |
Product NDC | 10019-450 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoclopramide Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20101209 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |